Not finding it? Sign in to also search OpenAlex live.
-
Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation2023 International Journal of Molecular Sciences article Medicine Atrial Fibrillation Management and Outcomes Open access cited by 1 patent
Stephan Nopp, M. Leontien van der Bent, Daniel Kraemmer, Oliver Königsbrügge, Johann Wojta, Ingrid Pabinger, +2 more
5citations -
Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: A report from the GLORIA ‐ AF registry phase III2024 Diabetes Obesity and Metabolism article Medicine Atrial Fibrillation Management and Outcomes Open access
Yang Liu, Chen Yang, Steven Ho Man Lam, Bi Huang, Giulio Francesco Romiti, Uazman Alam, +5 more
3citations -
Procedural and clinical impact of intracoronary lithotripsy in heavily calcified aorto‐ostial coronary lesions2024 Catheterization and Cardiovascular Interventions article Medicine Coronary Interventions and Diagnostics Open access
Federico Oliveri, Maura Meijer, Martijn J. H. van Oort, Ibtihal Al Amri, Brian O. Bingen, Bimmer E.P.M. Claessen, +7 more
2citations -
Small, dense LDL-C as a predictor of cardiovascular risk and benefit of alirocumab in patients with recent acute coronary syndrome receiving optimized statin treatment2026 American Journal of Preventive Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access
Gregory G. Schwartz, Michael J. Szarek, Christa M. Cobbaert, L. Renee Ruhaak, Markus Schwertfeger, Deepak L. Bhatt, +11 more
0citations -
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES)2021 Nephrology Dialysis Transplantation article Medicine Erythropoietin and Anemia Treatment Open access cited by 1 patent
Jonathan Barratt, Branislav Andrić, Avtandil Tataradze, Michael Schömig, Udaya Valluri, Christophe Mariat
151citations -
Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial
Gregory G. Schwartz, Michael J. Szarek, Deepak L. Bhatt, Vera Bittner, Maja Bujas‐Bobanovic, Rafael Díaz, +11 more
47citations -
Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice2022 International Journal of Cardiology article Medicine Diabetes Treatment and Management Open access
Edouard L. Fu, Catherine M. Clase, Roemer J. Janse, Bengt Lindholm, Friedo Wilhelm Dekker, Meg Jardine, +1 more
28citations -
Five-Year Outcomes and Prognostic Value of Feature-Tracking Cardiovascular Magnetic Resonance in Patients Receiving Early Prereperfusion Metoprolol in Acute Myocardial Infarction2020 The American Journal of Cardiology article Medicine Cardiovascular Function and Risk Factors Open access
Tomaž Podlesnikar, Gonzalo Pizarro, Rodrigo Fernández‐Jiménez, José Manuel Montero-Cabezas, Javier Sánchez‐Gonzalez, Chiara Bucciarelli‐Ducci, +6 more
21citations -
Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome2024 Journal of the American College of Cardiology article Medicine Lipoproteins and Cardiovascular Health Open access
Doron Zahger, Gregory G. Schwartz, Weiming Du, Michael J. Szarek, Deepak L. Bhatt, Vera Bittner, +15 more
15citations -
Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study2024 American Journal of Kidney Diseases article Medicine Diabetes Treatment and Management Open access
Emilie J. Lambourg, Edouard L. Fu, Stuart J. McGurnaghan, Bryan Ronald Conway, Neeraj Dhaun, Christopher Henry Grant, +13 more
7citations -
Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial2022 The American Journal of Medicine article Medicine Atrial Fibrillation Management and Outcomes Open access
Renato D. Lópes, Patrícia O. Guimarães, Gregory G. Schwartz, Deepak L. Bhatt, Vera Bittner, Andrzej Budaj, +12 more
6citations